BRIEF published on 04/02/2025 at 15:16, 1 year 5 months ago Vanguard Group met à jour sa position dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Achat D'actions Position Des Titres Assurance Direct Line
BRIEF published on 04/02/2025 at 15:16, 1 year 5 months ago Vanguard Group Updates Position in Direct Line Insurance Takeover Code Vanguard Group Share Purchase Direct Line Insurance Securities Position
PRESS RELEASE published on 04/02/2025 at 15:11, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group discloses 5.38% ownership of Direct Line Insurance Group plc in Form 8.3 filing on 01 April 2025 Form 8.3 Vanguard Group Ownership Disclosure Direct Line Insurance April 2025
BRIEF published on 03/28/2025 at 14:34, 1 year 5 months ago Vanguard Group dévoile sa position dans Direct Line Insurance et Aviva Groupe Vanguard Code De Prise De Contrôle Divulgation Des Valeurs Mobilières Aviva Plc Assurance Direct Line
BRIEF published on 03/28/2025 at 14:34, 1 year 5 months ago Vanguard Group Discloses Position in Direct Line Insurance and Aviva Takeover Code Securities Disclosure Vanguard Group Direct Line Insurance Aviva Plc
PRESS RELEASE published on 03/28/2025 at 14:29, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group PLC The Vanguard Group, Inc. discloses 5.38% stake in Direct Line Insurance Group PLC on 27 March 2025 The Vanguard Group Stock Market Stake Disclosure Financial Interest Direct Line Insurance Group Plc
BRIEF published on 03/27/2025 at 15:28, 1 year 5 months ago Vanguard Group Discloses Position in Direct Line Insurance Insurance Vanguard Group Financial Disclosure Shareholding Direct Line
BRIEF published on 03/27/2025 at 15:28, 1 year 5 months ago Le groupe Vanguard dévoile sa position dans Direct Line Insurance Assurance Actionnariat Groupe Vanguard Divulgation Financière Ligne Directe
PRESS RELEASE published on 03/27/2025 at 15:23, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.37% ownership of Direct Line Insurance Group plc. Purchase and sale transactions of 10 10/11p ordinary shares Vanguard Group Ownership Disclosure Direct Line Insurance Purchase Transactions Sale Transactions
BRIEF published on 03/26/2025 at 14:40, 1 year 5 months ago Vanguard Group Discloses Position in Direct Line Insurance Group Position Disclosure Takeover Code Vanguard Group Direct Line Insurance Aviva
Published on 09/11/2026 at 04:00, 6 hours 42 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 17 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 22 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 42 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 27 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 22 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 36 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 42 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 42 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 42 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 42 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 12 minutes ago Availability of the 2026 Interim Financial Report
